Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117740 · ClinicalTrials.gov registry record
Pleural Catheters Versus Thoracoscopic Pleurodesis
A clinical trial of Lung Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 445
- Enrollment target
- 1
- Study location
NCT01117740: Completed study of Lung Cancer, sponsored by M.D. Anderson Cancer Center.
NCT01117740 is a study of Lung Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 445 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01117740, a study of Lung Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 445 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research study is to compare 2 different methods for treating a pleural effusion. Researchers also want to learn how the treatment you receive effects your quality of life (your ability to do the things you like to do and how happy you feel.
Primary Outcome
Quality-adjusted time to death (measured as QALYs) for two patient groups (indwelling pleural catheters and thoracoscopy), calculated using Brazier's SF-6D utility measure described to determine utilities, then integrating utilities over time to arrive at quality-adjusted survival for each patient.
Conditions Studied
Interventions
- BEHAVIORAL MDASI Questionnaire
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 445 participants |
| Start Date | 2010-04 |
| Est. Completion | 2016-04 |
What the finished NCT01117740 record still lists
NCT01117740 is an observational study that tracks outcomes without assigning an intervention. The registered 445 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which MDASI Questionnaire is the first listed.
NCT01117740 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01117740 about?
NCT01117740 is a clinical study titled "Pleural Catheters Versus Thoracoscopic Pleurodesis". The goal of this clinical research study is to compare 2 different methods for treating a pleural effusion. Researchers also want to learn how the treatment you receive effects your quality of life (your ability to do the things you like to do and how happy you feel.
What is the current status of trial NCT01117740?
This trial is currently completed. The enrollment target is 445 participants. The study started on 2010-04. Estimated completion is 2016-04.
What conditions does trial NCT01117740 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT01117740?
The interventions under investigation include: MDASI Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT01117740?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01117740 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01117740's enrollment target sits among peer trials
445 78th of 409 higher than 332 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia